🛡️ Radvocacy in Action: A Battle on Two Fronts — Federal and State Advocacy
📅 Webinar Date & Time
Wednesday, August 27
6:00 PM – 7:00 PM Pacific Time
🔍 Webinar Overview
Join us for a dynamic and insightful webinar exploring the dual challenges and opportunities in radiology advocacy at both the federal and state levels. This session will unpack the strategic approaches, legislative landscapes, and collaborative efforts driving impactful change in healthcare policy. Whether you're a seasoned advocate or just beginning to engage in policy work, this webinar will provide valuable perspectives and actionable insights from leaders on the front lines of radiology advocacy.
🗣️ Featured Speakers
-
Joshua J. Cooper, Vice President of Government Affairs is a seasoned professional with over three decades of experience in government relations and health policy. As Vice President of Government Relations and Economic Policy at the American College of Radiology, he has spearheaded legislative initiatives nd made significant contribtions to the field. His expertise encompasses advocacy, strategic communications, and coalition building.
-
Senator Cathleen Galgiani served in the California State Assembly and Senate from 2006 to 2020, repsenting the Central Valley. In 2021, she was appointed by Governor Gavin Newsom s a Commissioner on the statewide Gambling Control Commission. Prior to serving in the Legislature, Galgian worked for Governor Gray Davis, Insurance Commissioner John Garamendi, Senator Patrickc Johnston and Assembly member Barbara Matthews. Galgiani has been representing CRS since 2024.
-
Ryan Spencer, Principal for RGS Consulting and Advocacy. Mr. Spencer has 28 years of legislative and political experience, much of it rooted in the California State Capitol. He served in the State Assembly under three Speakers, gainng deep epertise in legislative procedure and cultivating strong relationships with key Senate and Assembly staff. Since 2017, Ryan has been a dedicted advocate for the house of medicine and medical specialties and has represented CRS since 2024.
-
Ashley Walton, Government Affairs Director, has spent her career in advocacy, focusing on health policy. With over a decade of experience, she is committed to ensuring physician interests are represented in policymaking and advancing legislation that strengthens patient care.
-
Steven Wang, MD, MBA, is a radiologist with Southern California Permanente Medical Group in Bakersfield. He is an alternate delegate for the AMA’s IPPS section and secretary of the California Radiological Society. He is the founder and chair of CRS’s government affairs committee.
✅ What You’ll Learn
-
Key federal and state legislative priorities impacting radiology
-
How advocacy strategies differ across jurisdictions
-
Ways to get involved and make your voice heard
-
Real-world examples of successful advocacy efforts
📌 Register Now
Secure your spot and be part of the conversation shaping the future of radiology advocacy.
Program Materials
Requirements: 1. Radvocacy in Action: A Battle on Two Fronts — Federal and State Advocacy Campaigns
2. August 27, 2025
3.
Educational/Learning Objectives (verbatim from Activity Planning Form)
a. After completing this activity, the participant should be better able to:
i. Define why advocacy is crucial for patient care and access.
ii. Identify what resources are available to radiologists when carrying out advocacy endeavors.
iii. Describe how radiologists of all career levels can get involved at the state and national level.
iv. Analyze the potential impact of current and proposed legislation on radiology and radiation oncology.
v. Identify key legislative issues affecting patient access to care and physician reimbursement.
4.
Physician Accreditation Statement (must stand-alone) The American College of Radiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
5.
Physician Credit Designation (must stand-alone) The American College of Radiology designates this other activity (blend of live and enduring materials) for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.
Instructions to Receive Credit In order to successfully complete the activity, participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.
7.
Contact Information For information about the accreditation of this program, please contact the ACR at
https://www.acr.org/Contact.
8.
Disclosure of Relevant Financial Relationships The ACR Disclosure Policy: The American College of Radiology (ACR) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ACR are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ACR in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ACR to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ACR.
The following planners, managers, and reviewers have no relevant financial relationships to disclose: Andrea Alsup, Janine Katzen and Melody Ballesteros.
The following faculty members have no relevant financial relationships to disclose: Joshua J. Cooper, Cathleen Galgiani, Ryan Spencer, and Ashley Walton.
The faculty members (speakers, etc.) have the following identified relevant financial relationships: Steven Wang, MD - Stock Shareholder: Pfizer, Bristol-Meyers-Squibb
